Drug Description in Trials / DrugBank / KEGG DRUG

Search results

descriptions per page:

Showing 1 to 6 of 6 descriptions

Filter by

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	Anti-von Willebrand Factor Nanobody, Caplacizumab	2件: Caplacizumab, Von Willebrand factor human	1件: D11160 (Name: Caplacizumab)	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, F ...	1件: 64
2	Anti-von Willebrand Factor Nanobody, INN = Caplacizumab	2件: Caplacizumab, Von Willebrand factor human	1件: D11160 (Name: Caplacizumab)	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, F ...	1件: 64
3	CAPLACIZUMAB	1件: Caplacizumab	1件: D11160 (Name: Caplacizumab)	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, F ...	1件: 64
4	Caplacizumab (ALX-0081)	1件: Caplacizumab	1件: D11160 (Name: Caplacizumab)	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, F ...	1件: 64
5	Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081)	2件: Caplacizumab, Von Willebrand factor human	1件: D11160 (Name: Caplacizumab)	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, F ...	1件: 64
6	Caplacizumab (an anti-von Willebrand Factor Nanobody)	2件: Caplacizumab, Von Willebrand factor human	1件: D11160 (Name: Caplacizumab)	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, F ...	1件: 64

First Previous1Next Last